BRISTOL-MYERS SQUIBB COMPANY Prepaid Expense, Current
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Prepaid Expense, Current of $886.00 million as of 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2018-10-25
- 2018-09-30: Prepaid Expense, Current $886.00M.
- 2018-06-30: Prepaid Expense, Current $998.00M.
- 2018-03-31: Prepaid Expense, Current $965.00M.
- 2017-12-31: Prepaid Expense, Current $576.00M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2018-09-30 | $886.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $998.00M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $965.00M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $576.00M 10-Q · filed 2018-10-25 |
| 2017-09-30 | $754.00M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $820.00M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $628.00M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $570.00M 10-Q · filed 2017-10-26 |
| 2016-09-30 | $565.00M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $588.00M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $615.00M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $625.00M 10-Q · filed 2016-10-27 |
| 2015-09-30 | $529.00M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $502.00M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $538.00M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $470.00M 10-Q · filed 2015-10-27 |
| 2014-09-30 | $482.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $512.00M 10-Q · filed 2014-07-24 |
| 2014-03-31 | $538.00M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $412.00M 10-Q · filed 2014-10-24 |
| 2013-09-30 | $556.00M 10-Q · filed 2013-10-23 |
| 2013-06-30 | $536.00M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $616.00M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $355.00M 10-Q · filed 2013-10-23 |
| 2012-09-30 | $423.00M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $455.00M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $500.00M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $258.00M 10-K · filed 2013-02-15 |
| 2011-09-30 | $356.00M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $420.00M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $451.00M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $252.00M 10-K · filed 2012-02-17 |
| 2010-09-30 | $292.00M 10-Q · filed 2010-10-26 |
| 2010-06-30 | $296.00M 10-Q · filed 2010-07-22 |
| 2010-03-31 | $268.00M 10-Q · filed 2010-04-29 |
| 2009-12-31 | $256.00M 10-K · filed 2011-02-18 |
| 2009-09-30 | $493.00M 10-Q · filed 2009-10-22 |
| 2009-06-30 | $385.00M 10-Q · filed 2009-07-23 |
| 2008-12-31 | $320.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |